Lekaa Mohammad, MD

Department of Hematology and Oncology, Medical School and Teaching Hospital in Plzen, Charles University in Prague, Czech Republic

Poster(s):

• 1526 - Ibrutinib and acalabrutinib in the treatment of relapsed/refractory chronic lymphocytic leukemia: a real-world analysis from the Czech Chronic Lymphocytic Leukemia Patients Registry